Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping

NCT07804316 | Recruiting

• 2 other identifiers: RECAS-0658IG (S) 1/2024 - 1021
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

This project aims to develop mapping of food choices available for chronic kidney disease (CKD) patients when dining out in Singapore. Following the mapping, a mobile application will be developed based on renal dining out food map mobile application (RENDOFOMAP) and trialed on patients with CKD. The specific aims of the project include:

1. 1.Mapping out food choices suitable for patients with CKD when dining out in Singapore which will eventually be translated into a mobile application incorporating simple AI functionality.
2. 2.To evaluate the impact of using RENDOFOMAP on self-empowerment, quality of life, nutritional status, and serum biochemistry in patients with CKD.
3. 3.To evaluate the acceptability and user experience of RENDOFOMAP

Conditions

CKD; Chronic Kidney Disease (Stages 3b-5)

Keywords

artificial intelligence; nutrition app; renal nutrition

Outcome Measures

Primary Outcomes (5)

• Physical Health-Related Quality of Life

  Physical Health-Related Quality of Life At baseline and Week 12-16, physical health-related quality of life will be assessed using the 12-Item Short Form Health Survey (SF-12). The Physical Component Summary (PCS) score ranges from 5 to 20, with lower scores indicating better health-related quality of life and higher scores indicating poorer health-related quality of life.

  Baseline to the end of study at 12-16 weeks

• Mental Health-Related Quality of Life

  At baseline and Week 12-16, mental health-related quality of life will be assessed using the 12-Item Short Form Health Survey (SF-12). The Mental Component Summary (MCS) score ranges from 12 to 45, with lower scores indicating better health-related quality of life and higher scores indicating poorer health-related quality of life.

  Baseline to the end of study at 12-16 weeks

• Modified Nutrition-related Empowerment Scale

  At baseline and Week 12-16, nutrition-related empowerment will be assessed using a modified version of the Korean Health Empowerment Scale (K-HES). The scale consists of 8 items scored from 1 (Strongly Disagree) to 5 (Strongly Agree). Item scores are summed to generate a total score ranging from 8 to 40, with higher scores indicating greater nutrition-related empowerment and self-management capacity.

  Baseline to the end of study at 12-16 weeks

• Ease of Adherence to Diet Plan When Eating Out

  Participants will rate the ease of adhering to their prescribed diet plan when eating out using a 5-point scale ranging from 1 (very difficult) to 5 (very easy). Higher scores indicate greater ease of dietary adherence.

  Baseline to the end of study at 12-16 weeks

• Food Diary Completion Rate

  Participant engagement with the nEAT mobile application will be assessed by the proportion of scheduled food diary entries completed during the intervention period. Food diary completion rate (%) = (Number of completed food diary entries ÷ Total number of scheduled food diary entries) × 100. A food diary entry is considered completed when the participant records the required dietary information for the scheduled eating occasion within the nEAT mobile application

  Baseline to the end of study at 12-16 weeks

Secondary Outcomes (10)

• Body Weight Change

  Baseline to the end of study at 12-16 weeks

• Percentage Weight Change

  Baseline to the end of study at 12-16 weeks

• Body Mass Index (BMI)

  Baseline to the end of study at 12-16 weeks

• Nutritional Status [Subjective Global Assessment (SGA)}

  Baseline to the end of study at 12-16 weeks

• Ease of Adherence to Diet Plan When Eating at Home

  Baseline to the end of study at 12-16 weeks

Other Outcomes (5)

• Change in Estimated Glomerular Filtration Rate (eGFR)

  Baseline to the end of study at 12-16 weeks

• Change in Serum Creatinine

  Baseline to the end of study at 12-16 weeks

• Serum Potassium Concentration

  Baseline to the end of study at 12-16 weeks

Interventions

Mobile application empowerment approach OTHER

Participant will be provided access to the prototype mobile application known for this trial. Participants will be required to utilise the mobile application for 12 days (two 6-consecutive days, twice within 3 months) during a 3-month period. During the agreed dates, participant will need to take photos of their food intake and upload them onto the mobile application for evaluation.

Eligibility Criteria

• Age: 21 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants will be recruited from inpatient and outpatient setting in a tertiary hospital

You may qualify if:

• Are fluent in English. This is necessary to ensure clear communication and understanding of study procedures and materials.
• Adequate proficiency in using smartphone i.e. downloading app, taking photo, completing e-forms within the mobile applications. This is essential for participants to effectively use the mobile application being tested.
• Diagnosed with CKD Stage 3B-5. This targets the specific patient population that the study aims to benefit.

You may not qualify if:

• Only fluent in languages other than English. This could hinder effective communication and understanding of the study.
• Diagnosis of cognitive deficit or neurological disorder. These conditions could impair the ability to follow study procedures or provide reliable data.
• Uncontrolled diabetes (HbA1c\>8.5%). This condition could introduce additional health risks and confound study results.
• Recent hypoglycemic episodes. This could pose a safety risk during the study.
• Newly initiated on dialysis or planning for dialysis within the next 6 months. These patients may have rapidly changing health conditions that could affect study outcomes.
• Decompensated liver cirrhosis. This condition could complicate the interpretation of study results.
• Pregnant and lactating. These conditions could introduce additional variables that affect study outcomes.
• Inability to provide consent. This ensures that all participants can legally and ethically participate in the study

Sponsors & Collaborators

• Singapore Institute of Technology: lead
• Singapore General Hospital: collaborator
• Sengkang General Hospital: collaborator

Study Sites (1)

Singapore Institute of Technology

Singapore, 828608, Singapore

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Gary Tung Lin Chiah, MSc, BSc, RD

  Singapore Institute of Technology

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Gary Tung Lin Chiah, MSc, BSc, RD

CONTACT

+6565925769; gary.chiah@singaporetech.edu.sg

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Senior Lecturer

Study Record Dates

• First Submitted: July 19, 2026
• First Posted: September 4, 2026
• Study Start: April 15, 2026
• Primary Completion (Estimated): January 16, 2027
• Study Completion (Estimated): August 16, 2027
• Last Updated: September 4, 2026

Record last verified: 2025-10

Locations

SG (1)